NBIX

Neurocrine Biosciences, Inc. Press Releases

$47.31
*  
0.35
0.73%
Get NBIX Alerts
*Delayed - data as of Jul. 2, 2015  -  Find a broker to begin trading NBIX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia
6/8/2015 4:27:00 PM - PR Newswire
▲4.21 % Price Change since this news event. The Volume Ratio is 2.7.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences, Inc. Announces Appointment of Eric Benevich as Chief Commercial Officer
6/2/2015 8:00:00 AM - PR Newswire
▲13.24 % Price Change since this news event. The Volume Ratio is 1.07.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Neurocrine Biosciences to Present at the Jefferies 2015 Healthcare Conference
5/27/2015 3:54:00 PM - PR Newswire
▲10.13 % Price Change since this news event. The Volume Ratio is 2.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015
5/12/2015 4:01:00 PM - PR Newswire
▲18.16 % Price Change since this news event. The Volume Ratio is 1.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day